Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05227300 · ClinicalTrials.gov registry record · Phase 4

Buffered vs. Unbuffered Local Anesthesia in Mandibular Molars Diagnosed With Symptomatic Irreversible Pulpitis

A Phase 4 study, sponsored by Indiana University.

Completed
Registry status
Phase 4
Development phase
40
Enrollment target

NCT05227300 is a Phase 4 study that has completed, run by Indiana University. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05227300, a Phase 4 study, has completed, sponsored by Indiana University.

COMPLETED
Registry status
Phase 4
Development phase
40 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether one type of anesthetic (numbing medicine) will work better at numbing the nerve in a tooth than using a different type of anesthetic. A second purpose is to see if the time needed to numb the nerve in a tooth is different between the two anesthetics.

Interventions

  • DRUG 2% lidocaine with 1:100,000 epinephrine
  • DRUG Onset Sodium Bicarbonate Inj., 8.4%, USP Neutralizing Additive Solution

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-02-14
Est. Completion 2022-06-30
Phase Phase 4

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT05227300

The ClinicalTrials.gov registry entry for NCT05227300 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which 2% lidocaine with 1:100,000 epinephrine is the first listed.

NCT05227300 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05227300 about?

NCT05227300 is a clinical study titled "Buffered vs. Unbuffered Local Anesthesia in Mandibular Molars Diagnosed With Symptomatic Irreversible Pulpitis". The purpose of this study is to determine whether one type of anesthetic (numbing medicine) will work better at numbing the nerve in a tooth than using a different type of anesthetic. A second purpose is to see if the time needed to numb the nerve in a tooth is different between the two anesthetics.

What is the current status of trial NCT05227300?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2022-02-14. Estimated completion is 2022-06-30.

What interventions are being tested in trial NCT05227300?

The interventions under investigation include: 2% lidocaine with 1:100,000 epinephrine (DRUG), Onset Sodium Bicarbonate Inj., 8.4%, USP Neutralizing Additive Solution (DRUG).

Who is sponsoring clinical trial NCT05227300?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.